Related Experiment Videos
Leukocyte activation and function-associated antigens in inflammatory disease
M G Macey1, J M Wilton, R Carbon
1Royal London Hospital, UK.
Summary
Leukocyte activation markers are altered in rheumatoid arthritis (RA) and ankylosing spondylitis (AS) patients, but not in periodontitis. These changes suggest immune cell involvement in these inflammatory conditions.
Area of Science:
- Immunology
- Cell Biology
- Rheumatology
Background:
- Peripheral blood leukocyte (PBL) analysis is crucial for understanding immune responses in inflammatory diseases.
- Adhesion and function-associated molecules on PBLs can indicate cellular activation states.
Purpose of the Study:
- To investigate the expression of specific cell surface molecules on PBLs from patients with adult periodontitis (PD), ankylosing spondylitis (AS), and rheumatoid arthritis (RA).
- To determine if observed changes in antigen expression correlate with leukocyte activation in these conditions.
Main Methods:
- A novel rapid fixation technique was employed for leukocyte preparation to prevent antigen artifact.
- Flow cytometry was used to assay expression of CD11a, CD11b, CD18, CD3, CD4, CD8, CD16, CD19, CD56, and CD57 on PBLs.
- Analysis included normal controls, PD, AS, and RA patient groups.
Main Results:
- Rheumatoid arthritis (RA) patients showed decreased CD18+ lymphocytes and increased CD11b+ neutrophils. Lymphocyte CD11b and CD18 mean fluorescence intensity (MFI) decreased, while CD57 MFI increased.
- Ankylosing spondylitis (AS) patients exhibited increased CD11b+ lymphocytes and neutrophils, and decreased CD18+ lymphocytes and neutrophils. Lymphocyte CD11b and CD18 MFI decreased, CD16 MFI increased, and neutrophil CD18 MFI increased.
- No significant differences in antigen expression were observed in periodontitis (PD) patients compared to controls.
Conclusions:
- Altered antigen expression on PBLs in RA and AS patients suggests leukocyte activation.
- The findings indicate distinct immune cell activation patterns in RA and AS, differentiating them from PD.
- Leukocyte activation markers may serve as potential indicators for inflammatory rheumatic diseases.